51 – 60 of 335
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma phosphorylated tau 217 in preclinical Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Longitudinal amyloid and tau PET imaging in Alzheimer's disease : A systematic review of methodologies and factors affecting quantification
(
- Contribution to journal › Scientific review
-
Mark
Genetically identical twin-pair difference models support the amyloid cascade hypothesis
(
- Contribution to journal › Article
-
Mark
Associations of phosphorylated tau pathology with whole-hemisphere ex vivo morphometry in 7 tesla MRI
(
- Contribution to journal › Article
-
Mark
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Clinical performance and robustness evaluation of plasma amyloid-β42/40 prescreening
(
- Contribution to journal › Article
-
Mark
Longitudinal changes in hippocampal texture from healthy aging to Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Aging and Alzheimer's disease have dissociable effects on local and regional medial temporal lobe connectivity
(
- Contribution to journal › Article
-
Mark
Consensus recommendations for clinical assessment tools for the diagnosis of posterior cortical atrophy syndrome from the Atypical AD PIA of ISTAART
(
- Contribution to journal › Article